273 related articles for article (PubMed ID: 2883677)
21. Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
Herrmann WM; Schärer E; Wendt G; Delini-Stula A
Pharmacopsychiatry; 1991 Nov; 24(6):214-24. PubMed ID: 1812498
[TBL] [Abstract][Full Text] [Related]
22. Classification and assessment of cerebral bioavailability of lopirazepam (D-12524) by quantitative EEG and psychometric analysis.
Saletu B; Grünberger J; Linzmayer L; Stadler R
Arzneimittelforschung; 1980; 30(3):513-8. PubMed ID: 6104496
[TBL] [Abstract][Full Text] [Related]
23. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: psychometric and psychophysiological evaluation.
Grünberger J; Saletu B; Linzmayer L; Barbanoj MJ
Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):313-28. PubMed ID: 8412415
[TBL] [Abstract][Full Text] [Related]
24. Acute and subacute CNS effects of milacemide in elderly people: double-blind, placebo-controlled quantitative EEG and psychometric investigations.
Saletu B; Grünberger J; Linzmayer L
Arch Gerontol Geriatr; 1986 Oct; 5(3):165-81. PubMed ID: 3541816
[TBL] [Abstract][Full Text] [Related]
25. Classification and determination of pharmacodynamics of a new antihypoxidotic drug, vinconate, by pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L; Wittek R
Arch Gerontol Geriatr; 1984 Jul; 3(2):127-46. PubMed ID: 6476974
[TBL] [Abstract][Full Text] [Related]
26. Classification and bioavailability studies with WE 941 by quantitative pharmaco-EEG and clinical analyses.
Saletu B; Grünberger J; Volavka J; Berner P
Arzneimittelforschung; 1979; 29(4):700-4. PubMed ID: 582772
[TBL] [Abstract][Full Text] [Related]
27. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
[TBL] [Abstract][Full Text] [Related]
28. Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man.
Saletu B; Grünberger J; Rajna P; Karobath M
J Neural Transm; 1980; 49(1-2):63-86. PubMed ID: 6777458
[TBL] [Abstract][Full Text] [Related]
29. Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry.
Saletu B; Grünberger J; Anderer P; Linzmayer L; Zyhlarz G
J Neural Transm (Vienna); 1996; 103(1-2):191-216. PubMed ID: 9026373
[TBL] [Abstract][Full Text] [Related]
30. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
[TBL] [Abstract][Full Text] [Related]
31. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia.
Small JG; Milstein V; Small IF; Miller MJ; Kellams JJ; Corsaro CJ
Clin Electroencephalogr; 1987 Jul; 18(3):124-35. PubMed ID: 3652464
[TBL] [Abstract][Full Text] [Related]
32. Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping.
Saletu-Zyhlarz GM; Anderer P; Linzmayer L; Semlitsch HV; Assandri A; Prause W; Hassan Abu-Bakr M; Lindeck-Pozza E; Saletu B
Int J Neuropsychopharmacol; 2002 Sep; 5(3):199-215. PubMed ID: 12366873
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine.
Herrmann WM; Schärer E; Delini-Stula A
Pharmacopsychiatry; 1991 Nov; 24(6):196-205. PubMed ID: 1687485
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
Saletu B; Grünberger J; Linzmayer L; Semlitsch HV; Anderer P; Chwatal K
Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470
[TBL] [Abstract][Full Text] [Related]
35. [A quantitative pharmaco-EEG study on psychotropic properties of cerebral metabolic enhancers: comparison between young and elderly healthy volunteers].
Nobuhara K
Seishin Shinkeigaku Zasshi; 1993; 95(5):392-416. PubMed ID: 8356168
[TBL] [Abstract][Full Text] [Related]
36. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings.
Saletu-Zyhlarz GM; Anderer P; Wolzt M; Semlitsch HV; Assandri A; Nessi P; Nannipieri F; Rosini S; Saletu B
Neuropsychobiology; 2009; 59(2):100-9. PubMed ID: 19365150
[TBL] [Abstract][Full Text] [Related]
37. [Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].
Wetzel H; von Bardeleben U; Holsboer F; Benkert O
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():23-9. PubMed ID: 1683336
[TBL] [Abstract][Full Text] [Related]
38. Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor.
Saletu B; Grünberger J; Linzmayer L; Schwartz JJ; Haegele KD; Schechter PJ
Int J Psychophysiol; 1986 May; 4(1):63-80. PubMed ID: 3721943
[TBL] [Abstract][Full Text] [Related]
39. Classification and determination of cerebral biovailability of psychotropic drugs by quantitative "pharmaco-EEG" and psychometric investigations (studies with AX-A411-BS).
Saletu B; Grünberger J; Linzmayer L
Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):449-59. PubMed ID: 21853
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of pharmacodynamic properties of psychotropic drugs: quanitative EEG, psychometric and blood level investigations in normals and patients.
Saletu B; Grünberger J
Pharmakopsychiatr Neuropsychopharmakol; 1979 Jan; 12(1):45-58. PubMed ID: 419165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
